CADAS138 presents itself as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies demonstrate significant potential for CADAS138-targeted therapies to alleviate disease https://deannacmmn596904.blogdigy.com/a-promising-therapeutic-avenue-63493755